The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

Saved in:
Bibliographic Details
Published in:Leukemia 2020-10, Vol.34 (10), p.2790-2793
Main Authors: Lai, Peilong, Chen, Xiaomei, Qin, Le, Jiang, Zhiwu, Luo, Chenwei, Huang, Xin, Wu, Sujing, Ling, Wei, Wang, Yulian, Wang, Jinghua, Deng, Chenxin, Huang, Lisi, Zeng, Lingji, Lu, Zesheng, Zhong, Liye, Liao, Pengjun, Li, Minming, Chen, Dongmei, Geng, Suxia, Wu, Ping, Tang, Zhaoyang, Pei, Duanqing, Du, Xin, Li, Peng, Weng, Jianyu
Format: Article
Language:English
Subjects:
14/5
631/250/251
64/60
692/700/565/251
Animals
Cancer Research
Cell therapy
Critical Care Medicine
Development and progression
Disease Models, Animal
Female
Health aspects
Hematology
Hepatitis B
Hepatitis B - complications
Hepatitis B - diagnosis
Hepatitis B - immunology
Hepatitis B - virology
Hepatitis B virus - immunology
Humans
Immunotherapy, Adoptive - adverse effects
Immunotherapy, Adoptive - methods
Intensive
Internal Medicine
Letter
Lymphocytes
Lymphocytes T
Male
Medicine
Medicine & Public Health
Mice
Middle Aged
Oncology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen
T cells
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Treatment Outcome
Xenograft Model Antitumor Assays
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-020-0952-4